Medications

FDA approves lower-cost alternative to biotech drug Humira

Federal regulators on Friday approved the first alternative version of the second-best selling drug in the world, Humira, the blockbuster injection used to treat rheumatoid arthritis and other inflammatory diseases.

Oncology & Cancer

Pfizer reports promising results for cancer drug

An experimental drug has shown encouraging results in treating advanced breast cancer in an early clinical trial, pharmaceutical giant Pfizer reported Sunday.

Addiction

No time to waste on tackling fentanyl in New Zealand

Fentanyl has been circulating the international illicit drug market since about 2013 and is responsible for approximately half of all overdose deaths in the U.S. So it was perhaps inevitable it would eventually cause problems ...

page 3 from 5